Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated With Osteoarthritis in the Knee

NCT02022930 is registered in ClinicalTrials.gov with Carbylan Therapeutics, Inc. as lead sponsor.

NCT NCT02022930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02022930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated With Osteoarthritis in the Knee
Lead sponsor
Carbylan Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2014
Completion date
June 30, 2016
Enrollment
510 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of the knee